Greenyn Biotechnology Co., Ltd

Greenyn Biotechnology Co., Ltdverified

6846.TWO

Price:

$76.8

Market Cap:

$2.07B

Greenyn Biotechnology Co., Ltd, a dietary supplement company, develops, manufactures, and sells health products in Taiwan and internationally. The company offers proprietary ingredients, such as Insumate, a bitter melon extract; Antromax, an antrodia cinnamomea; and Zymologist 101 Phyto fermented drink. It also provides functional formulas for youth and beauty series, digestive health series, brain health series, body regulation series, throat moistening series, hair care series, clear eye series, colorful lifestyle series, joint health series, nutritional supplement series, energy supplement series, immune modulation series, low burden series, sleep aid series, body curve series, circulatio...[Read more]

Industry

Biotechnology

IPO Date

2022-04-19

Stock Exchange

TWO

Ticker

6846.TWO

The Enterprise Value as of December 2025 (TTM) for Greenyn Biotechnology Co., Ltd (6846.TWO) is 2.09B

According to Greenyn Biotechnology Co., Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 2.09B. This represents a change of 15.01% compared to the average of 1.82B of the last 4 quarters.

Greenyn Biotechnology Co., Ltd (6846.TWO) Historical Enterprise Value (quarterly & annually)

How has 6846.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Greenyn Biotechnology Co., Ltd over the last ten years is 1.72B. The current 2.09B Enterprise Value has changed 12.04% with respect to the historical average. Over the past ten years (40 quarters), 6846.TWO's Enterprise Value was at its highest in in the March 2023 quarter at 2.46B. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

1.72B

Median

1.71B

Minimum

1.65B

Maximum

1.87B

Greenyn Biotechnology Co., Ltd (6846.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Greenyn Biotechnology Co., Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.86%

Maximum Annual Enterprise Value = 1.87B

Minimum Annual Increase = -11.56%

Minimum Annual Enterprise Value = 1.65B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20241.68B-1.98%
20231.71B0.19%
20221.71B-1.41%
20211.73B4.86%
20201.65B-11.56%

Greenyn Biotechnology Co., Ltd (6846.TWO) Average Enterprise Value

How has 6846.TWO Enterprise Value performed in the past?

The current Enterprise Value of Greenyn Biotechnology Co., Ltd (6846.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.70B

5-year avg

1.70B

10-year avg

1.72B

Greenyn Biotechnology Co., Ltd (6846.TWO) Enterprise Value vs. Peers

How is 6846.TWO’s Enterprise Value compared to its peers?

Greenyn Biotechnology Co., Ltd’s Enterprise Value is greater than Advagene Biopharma Co., Ltd. (1.73B), less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.56B), less than Genomics BioSci & Tech. Co.,Ltd. (2.21B), less than Sunny Pharmtech Inc. (2.46B), greater than Winston Medical Supply Co., Ltd. (1.40B), greater than Crystalvue Medical Corporation (1.86B), greater than TSH Biopharm Corporation Limited (1.62B), less than Hcmed (2.28B), less than Meribank Biotech Co., Ltd (2.66B), greater than Chi Sheng Pharma & Biotech Co., Ltd (1.58B),

Build a custom stock screener for Greenyn Biotechnology Co., Ltd (6846.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenyn Biotechnology Co., Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Greenyn Biotechnology Co., Ltd (6846.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Greenyn Biotechnology Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Greenyn Biotechnology Co., Ltd's Enterprise Value?

What is the highest Enterprise Value for Greenyn Biotechnology Co., Ltd (6846.TWO)?

What is the 3-year average Enterprise Value for Greenyn Biotechnology Co., Ltd (6846.TWO)?

What is the 5-year average Enterprise Value for Greenyn Biotechnology Co., Ltd (6846.TWO)?

How does the current Enterprise Value for Greenyn Biotechnology Co., Ltd (6846.TWO) compare to its historical average?